Arcus Biosciences, Inc. (RCUS) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $2.9M. Most recent filing: Aug. 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 24, 2026 filed Aug. 21, 2026 | Azoy Alexander Chief Accounting Officer | $41,161 | 8,481 | 0% | Yes | |
|
|
||||||
| July 13, 2026 filed July 9, 2026 | Jaen Juan C. President | −$2,031,919 | 68,569 | −8% | Yes | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Jaen Juan C. President | −$877,501 | 31,431 | −3% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free